Express Scripts Holding Market Cap 2006-2018 | ESRX

Express Scripts Holding market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Express Scripts Holding market cap as of November 15, 2018 is $54.4B.
Sector Industry Market Cap Revenue
Medical Medical Services $54.401B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.342B 23.01
PRA Health Sciences (PRAH) United States $6.613B 27.00
Charles River Laboratories (CRL) United States $6.190B 21.70
Premier (PINC) United States $5.294B 18.04
HealthEquity (HQY) United States $5.236B 109.60
INC Research Holdings (SYNH) United States $5.099B 20.58
Teladoc (TDOC) United States $4.024B 0.00
NovoCure (NVCR) Jersey $2.835B 0.00
AMN Healthcare Services Inc (AMN) United States $2.676B 18.36
BioTelemetry (BEAT) United States $1.998B 35.29
Medpace Holdings (MEDP) United States $1.982B 24.53
Healthways (TVTY) United States $1.499B 18.44
Intrexon (XON) United States $1.343B 0.00
IKang Healthcare (KANG) China $1.129B 56.07
CareDx (CDNA) United States $1.027B 0.00
Natera (NTRA) United States $0.953B 0.00
China Cord Blood (CO) China $0.802B 21.29
Surgery Partners (SGRY) United States $0.665B 0.00
Apollo Medical Holdings (AMEH) United States $0.629B 0.00
Establishment Labs Holdings (ESTA) $0.566B 0.00
Civitas Solutions (CIVI) United States $0.520B 10.24
OncoCyte (OCX) United States $0.069B 0.00
Interpace Diagnostics (IDXG) United States $0.033B 0.00
Cancer Genetics (CGIX) United States $0.015B 0.00
OpGen (OPGN) United States $0.008B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.004B 0.00